English

SAVIENT PHARMACEUTICALS INC

EDGAR

SVNT Current report (8-K) · filed 2013-12-31

95 filing records in this dataset, filed from 1995-05-05 to 2013-12-31. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

6.57 million USD

2013 Q3 · USD

Exact inputs and evidence

Revenue: 6567000 USD Source

Operating margin

-202.82%

2013 Q3 · %

Exact inputs and evidence

Operating Income: -13319000 USD Source
Revenue: 6567000 USD Source

Operating cash flow

-17.6 million USD

2013 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -61959000 USD Source
Operating Cash Flow: -44384000 USD Source

Cash and cash equivalents: 28.4 million USD 2013-09-30 Source
Exact value

28441000 USD
Long-term debt including current maturities: 236 million USD 2013-09-30 Source
Exact value

235731000 USD
Shares outstanding: 73.6 million shares 2013-09-30 Source
Exact value

73627000 shares

Reported share-count change

0.78% · 570 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

73057000 shares · 2012-09-30· Source
73627000 shares · 2013-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Capital expenditure

377 thousand USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Capital expenditure: 234000 USD · 2010-01-01 – 2010-12-31 Source
Capital expenditure: 22000 USD · 2010-01-01 – 2010-09-30 Source
Capital expenditure: 29000 USD · 2011-01-01 – 2011-03-31 Source
Capital expenditure: 91000 USD · 2011-01-01 – 2011-06-30 Source
Capital expenditure: 29000 USD · 2011-01-01 – 2011-03-31 Source
Capital expenditure: 165000 USD · 2011-01-01 – 2011-09-30 Source
Capital expenditure: 91000 USD · 2011-01-01 – 2011-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2013-12-31.

Financial data available through: 2012-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2012-12-31
Operating income: 9 of 11 periods available· newest 2012-12-31
Net income: 9 of 11 periods available· newest 2012-12-31
Operating cash flow: 9 of 11 periods available· newest 2012-12-31
Capital expenditure: 9 of 11 periods available· newest 2010-12-31
Total assets: 10 of 11 periods available· newest 2012-12-31
Total liabilities: 1 of 11 periods available· newest 2004-12-31
Current assets: 10 of 11 periods available· newest 2012-12-31
Current liabilities: 10 of 11 periods available· newest 2012-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2012-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2012-12-31
Shares outstanding: 3 of 11 periods available· newest 2012-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+88.4%

Prior period

USD 9.57 million

2011-01-01 – 2011-12-31
Current period

USD 18.02 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

18023000 − 9565000 = 8458000 USD

9565000 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
18023000 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · SAVIENT PHARMACEUTICALS INC · 2012-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Year-over-year change in Revenue: 8458000 USD Concept: fundies:Revenue Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 18023000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/000119312513136648/svnt-20121231.xml#937017 Filing: 000119312513136648 Input fundies:Revenue: 9565000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/000119312513136648/svnt-20121231.xml#167000 Filing: 000119312513136648
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 16.29 million

Prior period

−USD 102.03 million

2011-01-01 – 2011-12-31
Current period

−USD 118.31 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

-118312000 − -102027000 = -16285000 USD

-102027000 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
-118312000 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · SAVIENT PHARMACEUTICALS INC · 2012-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Year-over-year change in Net income: -16285000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -118312000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/000119312513136648/svnt-20121231.xml#1024974 Filing: 000119312513136648 Input fundies:NetIncome: -102027000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/000119312513136648/svnt-20121231.xml#169502 Filing: 000119312513136648
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 2.14 million

Prior period

−USD 116.88 million

2011-01-01 – 2011-12-31
Current period

−USD 114.75 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

-114745000 − -116880000 = 2135000 USD

-116880000 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
-114745000 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SAVIENT PHARMACEUTICALS INC · 2012-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Year-over-year change in Operating cash flow: 2135000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -114745000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/000119312513136648/svnt-20121231.xml#588677 Filing: 000119312513136648 Input fundies:OperatingCashFlow: -116880000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/000119312513136648/svnt-20121231.xml#158988 Filing: 000119312513136648
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2012 2012-01-01 – 2012-12-31

Revenue USD 18.02 million 100% of revenue
Operating costs Derived USD 137.12 million 761% of revenue
Operating income −USD 119.1 million −661% of revenue
Tax, interest and other Derived −USD 786,000 −4.4% of revenue
Net income −USD 118.31 million −656% of revenue

Cash

Operating cash flow −USD 114.75 million −637% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2002 9.4%87%
2003 Net income was higher than operating income, so the split is not drawn.
2004 Operating loss: operating costs were 131% of revenue.
2005 Operating loss: operating costs were 129% of revenue.
2006 Operating loss: operating costs were 136% of revenue.
2007 Operating loss: operating costs were 593% of revenue.
2011 Operating loss: operating costs were 1,307% of revenue.
2012 Operating loss: operating costs were 761% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2002 2002-01-01 – 2002-12-31	102966000	89828000 Derived	13138000	3421000 Derived	9717000	-6352000 Derived	Source 2002-01-01 – 2002-12-31: 102966000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: 13138000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: 9717000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: 9194000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 15546000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	101103000	94840000 Derived	6263000	-6191000 Derived	12454000	9381000 Derived	Source 2003-01-01 – 2003-12-31: 101103000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: 6263000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: 12454000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: 17359000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 7978000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	62353000	81969000 Derived	-19616000	7899000 Derived	-27515000	7415000 Derived	Source 2004-01-01 – 2004-12-31: 62353000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -19616000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -27515000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: 10998000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 3583000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	49495000	63975000 Derived	-14480000	-20448000 Derived	5968000	6072000 Derived	Source 2005-01-01 – 2005-12-31: 49495000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -14480000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: 5968000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: 8250000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 2178000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	47514000	64519000 Derived	-17005000	-77330000 Derived	60325000	-21405000 Derived	Source 2006-01-01 – 2006-12-31: 47514000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -17005000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: 60325000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -18726000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 2679000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	14024000	83198000 Derived	-69174000	-20506000 Derived	-48668000	-41717000 Derived	Source 2007-01-01 – 2007-12-31: 14024000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -69174000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -48668000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -40799000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 918000 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	9565000	125001000 Derived	-115436000	-13409000 Derived	-102027000	Unavailable	Source 2011-01-01 – 2011-12-31: 9565000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -115436000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -102027000 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -116880000 USD Inspect Operating Cash Flow Open source
2012 2012-01-01 – 2012-12-31	18023000	137121000 Derived	-119098000	-786000 Derived	-118312000	Unavailable	Source 2012-01-01 – 2012-12-31: 18023000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -119098000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -118312000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -114745000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 18M 2012

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Revenue	102966000	Revenue: 102966000 Open source
20032003-12-31	Revenue	101103000	Revenue: 101103000 Open source
20042004-12-31	Revenue	62353000	Revenue: 62353000 Open source
20052005-12-31	Revenue	49495000	Revenue: 49495000 Open source
20062006-12-31	Revenue	47514000	Revenue: 47514000 Open source
20072007-12-31	Revenue	14024000	Revenue: 14024000 Open source
20112011-12-31	Revenue	9565000	Revenue: 9565000 Open source
20122012-12-31	Revenue	18023000	Revenue: 18023000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

88.4% 2012

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Year over year	No prior comparable period	Revenue: 102966000 Open source
20032003-12-31	Year over year	-1.8%	Revenue: 101103000 Open source Revenue: 102966000 Open source
20042004-12-31	Year over year	-38.3%	Revenue: 62353000 Open source Revenue: 101103000 Open source
20052005-12-31	Year over year	-20.6%	Revenue: 49495000 Open source Revenue: 62353000 Open source
20062006-12-31	Year over year	-4%	Revenue: 47514000 Open source Revenue: 49495000 Open source
20072007-12-31	Year over year	-70.5%	Revenue: 14024000 Open source Revenue: 47514000 Open source
20112011-12-31	Year over year	No prior comparable period	Revenue: 9565000 Open source
20122012-12-31	Year over year	88.4%	Revenue: 18023000 Open source Revenue: 9565000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -660.8% 2012

Net margin -656.5% 2012

Free cash flow margin -297.5% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Operating margin	12.8%	Operating Income: 13138000 Open source Revenue: 102966000 Open source
20032003-12-31	Operating margin	6.2%	Operating Income: 6263000 Open source Revenue: 101103000 Open source
20042004-12-31	Operating margin	-31.5%	Operating Income: -19616000 Open source Revenue: 62353000 Open source
20052005-12-31	Operating margin	-29.3%	Operating Income: -14480000 Open source Revenue: 49495000 Open source
20062006-12-31	Operating margin	-35.8%	Operating Income: -17005000 Open source Revenue: 47514000 Open source
20072007-12-31	Operating margin	-493.3%	Operating Income: -69174000 Open source Revenue: 14024000 Open source
20112011-12-31	Operating margin	-1,206.9%	Operating Income: -115436000 Open source Revenue: 9565000 Open source
20122012-12-31	Operating margin	-660.8%	Operating Income: -119098000 Open source Revenue: 18023000 Open source
20022002-12-31	Net margin	9.4%	Net Income: 9717000 Open source Revenue: 102966000 Open source
20032003-12-31	Net margin	12.3%	Net Income: 12454000 Open source Revenue: 101103000 Open source
20042004-12-31	Net margin	-44.1%	Net Income: -27515000 Open source Revenue: 62353000 Open source
20052005-12-31	Net margin	12.1%	Net Income: 5968000 Open source Revenue: 49495000 Open source
20062006-12-31	Net margin	127%	Net Income: 60325000 Open source Revenue: 47514000 Open source
20072007-12-31	Net margin	-347%	Net Income: -48668000 Open source Revenue: 14024000 Open source
20112011-12-31	Net margin	-1,066.7%	Net Income: -102027000 Open source Revenue: 9565000 Open source
20122012-12-31	Net margin	-656.5%	Net Income: -118312000 Open source Revenue: 18023000 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 102966000 Open source
20032003-12-31	Free cash flow margin	9.3%	Revenue: 101103000 Open source Operating Cash Flow: 17359000 Open source Capital Expenditure: 7978000 Open source
20042004-12-31	Free cash flow margin	11.9%	Revenue: 62353000 Open source Operating Cash Flow: 10998000 Open source Capital Expenditure: 3583000 Open source
20052005-12-31	Free cash flow margin	12.3%	Revenue: 49495000 Open source Operating Cash Flow: 8250000 Open source Capital Expenditure: 2178000 Open source
20062006-12-31	Free cash flow margin	-45%	Revenue: 47514000 Open source Operating Cash Flow: -18726000 Open source Capital Expenditure: 2679000 Open source
20072007-12-31	Free cash flow margin	-297.5%	Revenue: 14024000 Open source Operating Cash Flow: -40799000 Open source Capital Expenditure: 918000 Open source
20112011-12-31	Free cash flow margin	Not reported	Revenue: 9565000 Open source Operating Cash Flow: -116880000 Open source
20122012-12-31	Free cash flow margin	Not reported	Revenue: 18023000 Open source Operating Cash Flow: -114745000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -114.7M 2012

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Operating cash flow	Not reported	No source recorded
20032003-12-31	Operating cash flow	17359000	Operating Cash Flow: 17359000 Open source
20042004-12-31	Operating cash flow	10998000	Operating Cash Flow: 10998000 Open source
20052005-12-31	Operating cash flow	8250000	Operating Cash Flow: 8250000 Open source
20062006-12-31	Operating cash flow	-18726000	Operating Cash Flow: -18726000 Open source
20072007-12-31	Operating cash flow	-40799000	Operating Cash Flow: -40799000 Open source
20112011-12-31	Operating cash flow	-116880000	Operating Cash Flow: -116880000 Open source
20122012-12-31	Operating cash flow	-114745000	Operating Cash Flow: -114745000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -41.7M 2007

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Free cash flow	Unavailable	No source recorded
20032003-12-31	Free cash flow	9381000	Operating Cash Flow: 17359000 Open source Capital Expenditure: 7978000 Open source
20042004-12-31	Free cash flow	7415000	Operating Cash Flow: 10998000 Open source Capital Expenditure: 3583000 Open source
20052005-12-31	Free cash flow	6072000	Operating Cash Flow: 8250000 Open source Capital Expenditure: 2178000 Open source
20062006-12-31	Free cash flow	-21405000	Operating Cash Flow: -18726000 Open source Capital Expenditure: 2679000 Open source
20072007-12-31	Free cash flow	-41717000	Operating Cash Flow: -40799000 Open source Capital Expenditure: 918000 Open source
20112011-12-31	Free cash flow	Unavailable	Operating Cash Flow: -116880000 Open source
20122012-12-31	Free cash flow	Unavailable	Operating Cash Flow: -114745000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

37.5% 2004

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2002-12-31	Liabilities / assets	Not reported	Total Assets: 285431000 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 290540000 Open source
20042004-12-31	Liabilities / assets	37.5%	Total Liabilities: 96501000 Open source Total Assets: 257205000 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 222691000 Open source
2006-12-31	Liabilities / assets	Not reported	Total Assets: 197893000 Open source
2007-12-31	Liabilities / assets	Not reported	Total Assets: 167173000 Open source
2011-12-31	Liabilities / assets	Not reported	Total Assets: 197116000 Open source
2012-12-31	Liabilities / assets	Not reported	Total Assets: 119206000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.46× 2012

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Current assets / current liabilities	1.62×	Current Assets: 75928000 Open source Current Liabilities: 46869000 Open source
20032003-12-31	Current assets / current liabilities	1.87×	Current Assets: 83443000 Open source Current Liabilities: 44530000 Open source
20042004-12-31	Current assets / current liabilities	2.66×	Current Assets: 135501000 Open source Current Liabilities: 50992000 Open source
20052005-12-31	Current assets / current liabilities	5.07×	Current Assets: 105863000 Open source Current Liabilities: 20866000 Open source
20062006-12-31	Current assets / current liabilities	9.66×	Current Assets: 194858000 Open source Current Liabilities: 20164000 Open source
20072007-12-31	Current assets / current liabilities	8.28×	Current Assets: 158934000 Open source Current Liabilities: 19184000 Open source
20112011-12-31	Current assets / current liabilities	6.31×	Current Assets: 189635000 Open source Current Liabilities: 30065000 Open source
20122012-12-31	Current assets / current liabilities	3.46×	Current Assets: 109314000 Open source Current Liabilities: 31616000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2003 2003-01-01 – 2003-12-31	USD 12.45 million Exact value Exact value: 12454000 USD 2003-01-01 – 2003-12-31: 12454000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SAVIENT PHARMACEUTICALS INC · 2003-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Net Income: 12454000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: 12454000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0001125282-06-001844.txt#8838 The citation records this snapshot. The page link may show a newer release later.	USD 17.36 million Exact value Exact value: 17359000 USD 2003-01-01 – 2003-12-31: 17359000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SAVIENT PHARMACEUTICALS INC · 2003-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Operating Cash Flow: 17359000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 17359000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0001125282-06-001844.txt#9163 The citation records this snapshot. The page link may show a newer release later.	USD 7.98 million Exact value Exact value: 7978000 USD 2003-01-01 – 2003-12-31: 7978000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SAVIENT PHARMACEUTICALS INC · 2003-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Capital Expenditure: 7978000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7978000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0001125282-06-001844.txt#9215 The citation records this snapshot. The page link may show a newer release later.	USD 9.38 million Calculation and evidence 17359000 − 7978000 USD Exact free cash flow: 9381000 USD 2003-01-01 – 2003-12-31: 17359000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 7978000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SAVIENT PHARMACEUTICALS INC · 2003-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Free cash flow: 9381000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 17359000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0001125282-06-001844.txt#9163 Input fundies:CapitalExpenditure: 7978000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0001125282-06-001844.txt#9215 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 27.52 million Exact value Exact value: -27515000 USD 2004-01-01 – 2004-12-31: -27515000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SAVIENT PHARMACEUTICALS INC · 2004-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Net Income: -27515000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -27515000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000950123-07-004001.txt#24014 The citation records this snapshot. The page link may show a newer release later.	USD 11 million Exact value Exact value: 10998000 USD 2004-01-01 – 2004-12-31: 10998000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SAVIENT PHARMACEUTICALS INC · 2004-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Operating Cash Flow: 10998000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 10998000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000950123-07-004001.txt#25255 The citation records this snapshot. The page link may show a newer release later.	USD 3.58 million Exact value Exact value: 3583000 USD 2004-01-01 – 2004-12-31: 3583000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SAVIENT PHARMACEUTICALS INC · 2004-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Capital Expenditure: 3583000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3583000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000950123-07-004001.txt#25655 The citation records this snapshot. The page link may show a newer release later.	USD 7.42 million Calculation and evidence 10998000 − 3583000 USD Exact free cash flow: 7415000 USD 2004-01-01 – 2004-12-31: 10998000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 3583000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SAVIENT PHARMACEUTICALS INC · 2004-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Free cash flow: 7415000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 10998000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000950123-07-004001.txt#25255 Input fundies:CapitalExpenditure: 3583000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000950123-07-004001.txt#25655 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	USD 5.97 million Exact value Exact value: 5968000 USD 2005-01-01 – 2005-12-31: 5968000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SAVIENT PHARMACEUTICALS INC · 2005-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Net Income: 5968000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5968000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000950123-08-002988.txt#13575 The citation records this snapshot. The page link may show a newer release later.	USD 8.25 million Exact value Exact value: 8250000 USD 2005-01-01 – 2005-12-31: 8250000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SAVIENT PHARMACEUTICALS INC · 2005-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Operating Cash Flow: 8250000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 8250000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000950123-08-002988.txt#13979 The citation records this snapshot. The page link may show a newer release later.	USD 2.18 million Exact value Exact value: 2178000 USD 2005-01-01 – 2005-12-31: 2178000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SAVIENT PHARMACEUTICALS INC · 2005-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Capital Expenditure: 2178000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2178000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000950123-08-002988.txt#14158 The citation records this snapshot. The page link may show a newer release later.	USD 6.07 million Calculation and evidence 8250000 − 2178000 USD Exact free cash flow: 6072000 USD 2005-01-01 – 2005-12-31: 8250000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 2178000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SAVIENT PHARMACEUTICALS INC · 2005-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Free cash flow: 6072000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 8250000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000950123-08-002988.txt#13979 Input fundies:CapitalExpenditure: 2178000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000950123-08-002988.txt#14158 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	USD 60.33 million Exact value Exact value: 60325000 USD 2006-01-01 – 2006-12-31: 60325000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SAVIENT PHARMACEUTICALS INC · 2006-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Net Income: 60325000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: 60325000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000930413-09-001133.txt#11559 The citation records this snapshot. The page link may show a newer release later.	−USD 18.73 million Exact value Exact value: -18726000 USD 2006-01-01 – 2006-12-31: -18726000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SAVIENT PHARMACEUTICALS INC · 2006-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Operating Cash Flow: -18726000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18726000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000930413-09-001133.txt#12091 The citation records this snapshot. The page link may show a newer release later.	USD 2.68 million Exact value Exact value: 2679000 USD 2006-01-01 – 2006-12-31: 2679000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SAVIENT PHARMACEUTICALS INC · 2006-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Capital Expenditure: 2679000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2679000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000930413-09-001133.txt#12275 The citation records this snapshot. The page link may show a newer release later.	−USD 21.41 million Calculation and evidence -18726000 − 2679000 USD Exact free cash flow: -21405000 USD 2006-01-01 – 2006-12-31: -18726000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 2679000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SAVIENT PHARMACEUTICALS INC · 2006-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Free cash flow: -21405000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18726000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000930413-09-001133.txt#12091 Input fundies:CapitalExpenditure: 2679000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000930413-09-001133.txt#12275 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 48.67 million Exact value Exact value: -48668000 USD 2007-01-01 – 2007-12-31: -48668000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SAVIENT PHARMACEUTICALS INC · 2007-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Net Income: -48668000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -48668000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000930413-10-001201.txt#11439 The citation records this snapshot. The page link may show a newer release later.	−USD 40.8 million Exact value Exact value: -40799000 USD 2007-01-01 – 2007-12-31: -40799000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SAVIENT PHARMACEUTICALS INC · 2007-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Operating Cash Flow: -40799000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -40799000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000930413-10-001201.txt#11877 The citation records this snapshot. The page link may show a newer release later.	USD 918,000 Exact value Exact value: 918000 USD 2007-01-01 – 2007-12-31: 918000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SAVIENT PHARMACEUTICALS INC · 2007-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Capital Expenditure: 918000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 918000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000930413-10-001201.txt#11947 The citation records this snapshot. The page link may show a newer release later.	−USD 41.72 million Calculation and evidence -40799000 − 918000 USD Exact free cash flow: -41717000 USD 2007-01-01 – 2007-12-31: -40799000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 918000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SAVIENT PHARMACEUTICALS INC · 2007-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Free cash flow: -41717000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -40799000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000930413-10-001201.txt#11877 Input fundies:CapitalExpenditure: 918000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0000930413-10-001201.txt#11947 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	Unavailable Not reported for this period.	Unavailable Not reported for this period.	USD 268,000 Exact value Exact value: 268000 USD 2008-01-01 – 2008-12-31: 268000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SAVIENT PHARMACEUTICALS INC · 2008-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Capital Expenditure: 268000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 268000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0001193125-11-051607.txt#9203 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2009 2009-01-01 – 2009-12-31	Unavailable Not reported for this period.	Unavailable Not reported for this period.	USD 71,000 Exact value Exact value: 71000 USD 2009-01-01 – 2009-12-31: 71000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SAVIENT PHARMACEUTICALS INC · 2009-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Capital Expenditure: 71000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 71000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0001193125-11-051607.txt#9203 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2010 2010-01-01 – 2010-12-31	−USD 73.11 million Exact value Exact value: -73109000 USD 2010-01-01 – 2010-12-31: -73109000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SAVIENT PHARMACEUTICALS INC · 2010-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Net Income: -73109000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -73109000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/000119312513136648/svnt-20121231.xml#129238 Filing: 000119312513136648 The citation records this snapshot. The page link may show a newer release later.	−USD 52.43 million Exact value Exact value: -52427000 USD 2010-01-01 – 2010-12-31: -52427000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SAVIENT PHARMACEUTICALS INC · 2010-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Operating Cash Flow: -52427000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -52427000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/000119312513136648/svnt-20121231.xml#121418 Filing: 000119312513136648 The citation records this snapshot. The page link may show a newer release later.	USD 234,000 Exact value Exact value: 234000 USD 2010-01-01 – 2010-12-31: 234000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SAVIENT PHARMACEUTICALS INC · 2010-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Capital Expenditure: 234000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 234000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0001193125-11-051607.txt#9203 The citation records this snapshot. The page link may show a newer release later.	−USD 52.66 million Calculation and evidence -52427000 − 234000 USD Exact free cash flow: -52661000 USD 2010-01-01 – 2010-12-31: -52427000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 234000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SAVIENT PHARMACEUTICALS INC · 2010-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Free cash flow: -52661000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -52427000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/000119312513136648/svnt-20121231.xml#121418 Filing: 000119312513136648 Input fundies:CapitalExpenditure: 234000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/0001193125-11-051607.txt#9203 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 102.03 million Exact value Exact value: -102027000 USD 2011-01-01 – 2011-12-31: -102027000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SAVIENT PHARMACEUTICALS INC · 2011-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Net Income: -102027000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -102027000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/000119312513136648/svnt-20121231.xml#169502 Filing: 000119312513136648 The citation records this snapshot. The page link may show a newer release later.	−USD 116.88 million Exact value Exact value: -116880000 USD 2011-01-01 – 2011-12-31: -116880000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SAVIENT PHARMACEUTICALS INC · 2011-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Operating Cash Flow: -116880000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -116880000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/000119312513136648/svnt-20121231.xml#158988 Filing: 000119312513136648 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2012 2012-01-01 – 2012-12-31	−USD 118.31 million Exact value Exact value: -118312000 USD 2012-01-01 – 2012-12-31: -118312000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SAVIENT PHARMACEUTICALS INC · 2012-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Net Income: -118312000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -118312000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/000119312513136648/svnt-20121231.xml#1024974 Filing: 000119312513136648 The citation records this snapshot. The page link may show a newer release later.	−USD 114.75 million Exact value Exact value: -114745000 USD 2012-01-01 – 2012-12-31: -114745000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SAVIENT PHARMACEUTICALS INC · 2012-12-31 SAVIENT PHARMACEUTICALS INC (edgar:722104) Operating Cash Flow: -114745000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:57:55Z Snapshot: d8a6e76a28467c97c28a008aff620f071edf52ba7a898d8da435a6cdf44e9738 Dimensions: Consolidated View: https://fundies.io/companies/edgar/722104/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -114745000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/722104/000119312513136648/svnt-20121231.xml#588677 Filing: 000119312513136648 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

95 filings · 1,567 latest values · 1,567 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000722104, 722104, SVNT, SVNTQ, edgar:722104, svnt

Also known as BIO TECHNOLOGY GENERAL CORP, SAVIENT PHARMACEUTICALS INC

SAVIENT PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2012 2012-01-01 – 2012-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation